About Evommune
Evommune is a private company based in Palo Alto, California, incorporated in 2020 in Delaware. It has reported $267,262,382 raised in four offerings on Form D since January 2025.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Oct 30, 2024 | Jan 8, 2025 | $115,499,956fully sold | 25 | $4.6M | EquityRule 506(b) | Form D ↗ |
| Mar 28, 2023 | Jan 8, 2025 | $57,500,000fully sold | 16 | $3.5M | EquityRule 506(b) | Form D ↗ |
| Aug 31, 2021 | Jan 8, 2025 | $81,799,952of $84.4M target | 10 | $8.1M | EquityRule 506(b) | Form D ↗ |
| Jun 22, 2020 | Jan 7, 2025 | $12,462,474fully sold | 18 | $692K | EquityRule 506(b) | Form D ↗ |
| Total, four offerings | $267,262,382 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Evommune's Form D filed Jan 8, 2025.
DD
Derek DiRocco
Director
EB
Eugene Bauer
Executive officer and director
FW
Felice Verduyn-van Weegen
Director
RH
Robert Hopfner
Director
KC
Kyle Carver
Executive officer
DC
David Cohen
Director
GM
Gregory Moss
Chief Business and Legal Officer
FB
BM
Benjamin McGraw
Director
JP
Jeegar Patel
Executive officer
YY
Yuexin Yu
Director
JD
Janice Drew
Executive officer
LP
Luis Pena
Executive officer and director